• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

0.00 0.00 (0.00%)

Quote as of

NOVADEL PHARMA INC

NASDAQOTCBB:NVDL.OB

Jump to this page for:

Related Resources

NovaDel Reports Unaudited Financial Results for Fourth Quarter and Year Ended December 31, 2011

3/20/2012 by Business Wire

Apricus Biosciences acquires NitroMist rights outside N.A. from NovaDel

2/3/2012 by Theflyonthewall.com

NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product

1/20/2012 by Business Wire

NovaDel Continuing to Explore Strategic Alternatives

1/18/2012 by Business Wire

NovaDel Reports Financial Results for Third Quarter 2011

11/1/2011 by Business Wire

NovaDel Pharma Inc. Recent Events

8/30/2011 by PharmiWeb.com - UK

NovaDel Pharma signs distribution agreement with Rechon Life Science

8/22/2011 by Theflyonthewall.com

NovaDel Pharma Inc. to Present at 2011 BIO International Convention

6/24/2011 by PharmiWeb.com - UK

NovaDel Pharma names CEO Steven B. Ratoff as interim CFO

6/9/2011 by Theflyonthewall.com

NovaDel Reports Opening of Duromist™ original IND with FDA

6/2/2011 by PharmiWeb.com - UK

NovaDel Pharma develops spray to replace Viagra, Globes reports

4/12/2011 by Theflyonthewall.com

NovaDel Pharma Inc. to Present at ROTH 23rd Annual OC Growth Stock Conference

3/11/2011 by PharmiWeb.com - UK

NovaDel Announces $1.6 Million Equity Financing

2/15/2011 by StockHouse

Zolpimist™ Oral Spray Launched in United States

2/4/2011 by PharmiWeb.com - UK

NovaDel Pharma Inc. Receives $500,000 Milestone Payment

1/7/2011 by PharmaLive

NovaDel Pharma Inc. Receives $500,000 Milestone Payment

1/7/2011 by Business Wire

NovaDel Pharma to Present at Biotech Showcase 2011

1/5/2011 by Business Wire

NovaDel Pharma, Inc. (NVDL) - Financial and Strategic SWOT Analysis Review - new company profile published

12/22/2010 by PR-inside - Austria

New Market Report Now Available: NovaDel Pharma, Inc. - Product Pipeline Review - Q4 2010

11/24/2010 by PR-inside - Austria

NovaDel Pharma reports $1.13m net loss in Q3

11/15/2010 by Pharmaceutical Business Review Online - UK

NovaDel Pharma Reports Recent Events and Financial Results for Third Quarter 2010

11/12/2010 by StockWatch

NovaDel Pharma Reports Recent Events and Financial Results for Third Quarter 2010

11/12/2010 by Business Wire

NovaDel Pharma gets milestone payment under NitroMist pact

11/5/2010 by Pharmaceutical Business Review Online - UK

NovaDel Pharma Inc. Receives $500,000 Milestone Payment

11/4/2010 by PharmaLive

NovaDel Pharma Inc. Receives $500,000 Milestone Payment

11/4/2010 by Business Wire

NovaDel Pharma gets IRS QTDP grant

11/4/2010 by Pharmaceutical Business Review Online - UK

NovaDel Pharma Inc. Awarded $244,479 Grant from Qualifying Therapeutic Discovery Project Program

11/3/2010 by PR-inside - Austria

NovaDel Pharma Inc. Awarded $244,479 Grant from Qualifying Therapeutic Discovery Project Program

11/3/2010 by Business Wire

NovaDel Pharma Inc. Announces Positive Data From Pilot Pharmacokinetic Study Comparing Duromist™ (Sildenafil Citrate Oral Spray) To Viagra(R)

10/20/2010 by Medical News Today - UK

NovaDel Pharma presents sildenafil citrate oral spray formulation study results

10/18/2010 by Pharmaceutical Business Review Online - UK

NovaDel Pharma Inc. Announces Positive Data from Pilot Pharmacokinetic Study Comparing Duromist™ (sildenafil citrate oral spray) ..

10/15/2010 by PR-inside - Austria

NovaDel Pharma Inc. Announces Positive Data from Pilot Pharmacokinetic Study Comparing Duromist™ (sildenafil citrate oral spray) to Viagra® Tablet

10/15/2010 by Business Wire

NovaDel Pharma Inc. Announces Appointment of Craig Johnson as Senior Vice President, Chief Financial Officer and Secretary

6/9/2010 by PharmaLive

NovaDel Pharma receives issue notification from new U.S. patent

12/15/2009 by Theflyonthewall.com